Bridging the Gap: Direct-to-Patient Strategies to Support Diversity in Clinical Trials

This webinar will explore the latest trends in the clinical trial industry, emphasizing direct-to-patient trial strategies and their impact on diversity, equity and inclusion (DEI). Reaching marginalized communities is a critical component for fulfilling study enrollment, yet these communities often face unique challenges.

One significant hurdle is the financial burden placed on patients due to the leveraging of patient insurance, which can hinder study enrollment and impact efforts to improve clinical trial diversity in the United States. Current industry trends are centered on patient-centric approaches such as DEI, accelerated start-up timelines and decentralized clinical trials.

Prioritizing patient-centricity can significantly enhance patient experience and enrollment, leading to more successful clinical trials. In addition, as clinical trial sites manage numerous studies simultaneously, it is essential to develop supply strategies that simplify the management of investigational medicinal products (IMPs) and non-IMPs (NIMPs).

This webinar will dive into how patient-centric supply strategies can address these complexities, improve trial efficiency and support clinical trial diversity. Through case studies, the featured speakers will examine various sourcing options for sponsors, highlighting their benefits and drawbacks for sponsors, patients and sites. Additionally, the discussion will cover how comparator drug supply vendors handle complex trial designs and access to specialty drugs, ensuring that patient needs are met efficiently.

Register for this webinar to learn about innovative, on-demand local sourcing solutions, methods to minimize cost and waste in clinical trials and how clinical trial diversity can benefit both sites and patients.

Speakers

Samit Bhatt, Vice President, Clinical Trial Patient Solutions, Myonex

Samit Bhatt is the Vice President for the Clinical Trial Patient Solutions team at Myonex. He is responsible for the team’s growing global operations in North America, Europe, Australia and New Zealand. Samit has over 13 years’ experience in the pharmacy and pharmaceutical industry; managing successful formulary status and relationship management with payers, significant understanding of healthcare contracts and knowledge of medical and pharmacy benefits, including specialized knowledge across different therapeutic areas. Samit holds both a Doctor of Pharmacy degree and an MBA from Drake University.

Message Presenter

Todd Luckritz, Associate Director, Clinical Trial Patient Solutions, Myonex

Todd Luckritz is the Associate Director for the Clinical Trials Patient Solutions team at Myonex. He is responsible for the team’s operations in North America. He has over 22 years’ experience as a Critical Care Pharmacist and as a Lead Pharmacist for the Investigational Drug Services Pharmacy Team at the Mayo Clinic in Phoenix, Arizona, where he managed a diverse portfolio of clinical trials from all therapeutic areas. Todd has extensive knowledge and experience of clinical trial operations of Phase I-IV studies at clinical trial sites and pharmacies. Todd holds a Doctor of Pharmacy degree.

Message Presenter